Toll Free: 1-888-928-9744

TrovaGene, Inc. (TROV) - Product Pipeline Analysis, 2016 Update

Published: May 25, 2016 | Pages: 48 | Publisher: GlobalData | Industry: Medical Devices | Report Format: Electronic (PDF)

Summary

TrovaGene, Inc. (TrovaGene), is a development stage molecular diagnostic company focusing on the development and commercialization of proprietary diagnostic technologies for screening and monitoring of various diseases. The company's proprietary urine-based molecular diagnostic tests are used in detection of transrenal DNA (TrDNA) and RNA (TrRNA). The technology is used in tumor detection and monitoring, prenatal genetic testing, infectious diseases, tissue transplantation, forensic identification, and for patient selection in clinical trials. It out-licenses its transrenal technologies to extend oncogene mutation detection using urine as a sample. The company has worldwide rights to worldwide rights to nucleophosmin-1 (NPM1), an informative biomarker for acute myelogenous leukemia (AML) and mutations in the SF3B1 gene. TrovaGene is headquartered in San Diego, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.  

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company TrovaGene, Inc.
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons To Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline 
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
 Table of Contents
Table of Contents 2 List of Tables 4 List of Figures 6 TrovaGene, Inc. Company Snapshot 7 TrovaGene, Inc. Company Overview 7 TrovaGene, Inc. Pipeline Products and Clinical Trials Overview 8 TrovaGene, Inc. - Pipeline Analysis Overview 10 Business Description 10 Key Facts 10 TrovaGene, Inc. - Major Products and Services 11 TrovaGene, Inc. Pipeline Products by Development Stage 12 TrovaGene, Inc. Pipeline Products Overview 14 Anti-TNF Panel Assay 14 Anti-TNF Panel Assay Product Overview 14 Cell-free DNA Mutation Assay 15 Cell-free DNA Mutation Assay Product Overview 15 Diagnostic Assay - Chronic Lymphocytic Leukemia 16 Diagnostic Assay - Chronic Lymphocytic Leukemia Product Overview 16 Diagnostic Assay - HBV 17 Diagnostic Assay - HBV Product Overview 17 Diagnostic Assay - Lyme Disease 18 Diagnostic Assay - Lyme Disease Product Overview 18 Diagnostic Assay - p53 19 Diagnostic Assay - p53 Product Overview 19 Diagnostic Assay - PIK3CA 20 Diagnostic Assay - PIK3CA Product Overview 20 Diagnostic Test - JC Virus 21 Diagnostic Test - JC Virus Product Overview 21 Diagnostic Test - Liver Cancer 22 Diagnostic Test - Liver Cancer Product Overview 22 EBV Diagnostic Assay 23 EBV Diagnostic Assay Product Overview 23 EGFR Mutation Detection Test - Lung Cancer 24 EGFR Mutation Detection Test - Lung Cancer Product Overview 24 HIV Tr-DNA Genotype Test 25 HIV Tr-DNA Genotype Test Product Overview 25 HPV Diagnostic Test - Men 26 HPV Diagnostic Test - Men Product Overview 26 miRNA Test - Alzheimer's Disease 27 miRNA Test - Alzheimer's Disease Product Overview 27 miRNA Test - Brain Stroke 28 miRNA Test - Brain Stroke Product Overview 28 miRNA Test - Kidney Transplantation 29 miRNA Test - Kidney Transplantation Product Overview 29 Next Generation CMOS Sensor Detection Platform 30 Next Generation CMOS Sensor Detection Platform Product Overview 30 Non Invasive Prenatal Screening Test 31 Non Invasive Prenatal Screening Test Product Overview 31 TB Tr-DNA Virulence Test 32 TB Tr-DNA Virulence Test Product Overview 32 Tr-DNA based Anthrax assay 33 Tr-DNA based Anthrax assay Product Overview 33 Tr-DNA based H. pylori assay 34 Tr-DNA based H. pylori assay Product Overview 34 Tr-DNA based HIV proviral DNA assay 35 Tr-DNA based HIV proviral DNA assay Product Overview 35 Tr-DNA based Leishmania assay 36 Tr-DNA based Leishmania assay Product Overview 36 Tr-DNA Malaria assay 37 Tr-DNA Malaria assay Product Overview 37 Tr-DNA Tuberculosis Assay 38 Tr-DNA Tuberculosis Assay Product Overview 38 TrovaGene, Inc. - Key Competitors 39 TrovaGene, Inc. - Key Employees 40 TrovaGene, Inc. - Key Employee Biographies 41 TrovaGene, Inc. - Locations And Subsidiaries 42 Head Office 42 Other Locations & Subsidiaries 42 Recent Developments 43 TrovaGene, Inc., Recent Developments 43 May 19, 2016: Large Clinical Data Set in Lung Cancer Featuring Trovagene's Precision Cancer Monitoring Platform Selected for Oral Presentation at the 2016 ASCO Annual Meeting 43 May 19, 2016: Large Clinical Data Set in Lung Cancer Featuring Trovagene's Precision Cancer Monitoring Platform Selected for Oral Presentation at the 2016 ASCO Annual Meeting 43 May 13, 2016: Large Clinical Study Demonstrates High Detection Rate and Ability to Monitor KRAS Mutations in Pancreatic Cancer Patients; Results Presented at 2016 AACR Pancreatic Cancer Meeting 43 May 10, 2016: Trovagene Announces First Quarter 2016 Financial Results 44 Apr 25, 2016: Trovagene Appoints Bill Welch as Chief Executive Officer 45 Apr 15, 2016: Patient Case Report Demonstrating the Ability of Trovagene's Precision Cancer Monitoring Platform to Determine Early Drug Response Published in Cancer Discovery 45 Apr 11, 2016: Trovagene Enters Into Preferred Provider Agreement with Stratose PPO Network 46 Apr 07, 2016: Clinical Data Featuring Trovagene's Precision Cancer Monitoring Platform to be Presented at the Molecular DX Europe Conference 46 Mar 28, 2016: Trovagene Terminates the Employment of CEO Antonius Schuh and CFO Stephen Zaniboni for Cause 46 Mar 24, 2016: Clinical Study Results Featuring Trovagene's Precision Cancer Monitoring Platform to be Presented at the AACR Annual Meeting 2016 47 Appendix 48 Methodology 48 About GlobalData 48 Contact Us 48 Disclaimer 48
List of Tables
TrovaGene, Inc. Pipeline Products and Clinical Trials Overview 8 TrovaGene, Inc. Pipeline Products by Equipment Type 8 TrovaGene, Inc. Pipeline Products by Indication 9 TrovaGene, Inc., Key Facts 10 TrovaGene, Inc., Major Products and Services 11 TrovaGene, Inc. Number of Pipeline Products by Development Stage 12 TrovaGene, Inc. Pipeline Products Summary by Development Stage 13 Anti-TNF Panel Assay - Product Status 14 Anti-TNF Panel Assay - Product Description 14 Cell-free DNA Mutation Assay - Product Status 15 Cell-free DNA Mutation Assay - Product Description 15 Diagnostic Assay - Chronic Lymphocytic Leukemia - Product Status 16 Diagnostic Assay - Chronic Lymphocytic Leukemia - Product Description 16 Diagnostic Assay - HBV - Product Status 17 Diagnostic Assay - HBV - Product Description 17 Diagnostic Assay - Lyme Disease - Product Status 18 Diagnostic Assay - Lyme Disease - Product Description 18 Diagnostic Assay - p53 - Product Status 19 Diagnostic Assay - p53 - Product Description 19 Diagnostic Assay - PIK3CA - Product Status 20 Diagnostic Assay - PIK3CA - Product Description 20 Diagnostic Test - JC Virus - Product Status 21 Diagnostic Test - JC Virus - Product Description 21 Diagnostic Test - Liver Cancer - Product Status 22 Diagnostic Test - Liver Cancer - Product Description 22 EBV Diagnostic Assay - Product Status 23 EBV Diagnostic Assay - Product Description 23 EGFR Mutation Detection Test - Lung Cancer - Product Status 24 EGFR Mutation Detection Test - Lung Cancer - Product Description 24 HIV Tr-DNA Genotype Test - Product Status 25 HIV Tr-DNA Genotype Test - Product Description 25 HPV Diagnostic Test - Men - Product Status 26 HPV Diagnostic Test - Men - Product Description 26 miRNA Test - Alzheimer's Disease - Product Status 27 miRNA Test - Alzheimer's Disease - Product Description 27 miRNA Test - Brain Stroke - Product Status 28 miRNA Test - Brain Stroke - Product Description 28 miRNA Test - Kidney Transplantation - Product Status 29 miRNA Test - Kidney Transplantation - Product Description 29 Next Generation CMOS Sensor Detection Platform - Product Status 30 Next Generation CMOS Sensor Detection Platform - Product Description 30 Non Invasive Prenatal Screening Test - Product Status 31 Non Invasive Prenatal Screening Test - Product Description 31 TB Tr-DNA Virulence Test - Product Status 32 TB Tr-DNA Virulence Test - Product Description 32 Tr-DNA based Anthrax assay - Product Status 33 Tr-DNA based Anthrax assay - Product Description 33 Tr-DNA based H. pylori assay - Product Status 34 Tr-DNA based H. pylori assay - Product Description 34 Tr-DNA based HIV proviral DNA assay - Product Status 35 Tr-DNA based HIV proviral DNA assay - Product Description 35 Tr-DNA based Leishmania assay - Product Status 36 Tr-DNA based Leishmania assay - Product Description 36 Tr-DNA Malaria assay - Product Status 37 Tr-DNA Malaria assay - Product Description 37 Tr-DNA Tuberculosis Assay - Product Status 38 Tr-DNA Tuberculosis Assay - Product Description 38 TrovaGene, Inc., Key Employees 40 TrovaGene, Inc., Key Employee Biographies 41 TrovaGene, Inc., Other Locations 42


List of Figures
TrovaGene, Inc. Pipeline Products by Equipment Type 9 TrovaGene, Inc. Pipeline Products by Development Stage 12

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global commercial drone market size is estimated to reach USD 2,069.6 million by 2022, as per a new research report by Radiant Insights, Inc. Increasing application of these machines in various industry sectors such as military, agriculture and energ

Read More...

Global non destructive testing equipment market is anticipated to reach USD 5.76 billion by 2022, as per a new research report by Radiant Insights, Inc. Stringent government safety initiatives for inspection and quality control across numerous indust

Read More...

Global LCP (Liquid Crystal Polymer) industry is forecasted to reach USD 1.23 billion by 2020, as per a new research report by Radiant Insights, Inc. Growing trend towards developing militarized components and connectors are likely to drive the demand

Read More...

Global geotextile market size is likely to be valued at USD 8.24 billion by 2020; as per a new research report by Radiant Insights, Inc. Increasing use in soil reinforcement activity coupled with growing application scope in road & railway developmen

Read More...

Global coated fabrics market size forecast is estimated at USD 22.57 billion by 2020; as per a new research report by Radiant Insights, Inc. Increasing production of seat covers & airbags for automobile applications is likely to favor market growth.

Read More...
Choose License Type
Single User - US $750
Multi User - US $1500
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify